PC

Punjab Chemicals & Crop Protection Ltd

Q3 FY26Fertilizers & Agrochemicals

Punjab Chemicals & Crop Protection Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹1,148
Market cap₹1.3K Cr
P/E20.1
Updated23 Aug 2026
Read4 min read

The short version

The company expects a revenue growth of about 15% to 20% year-on-year over the next few years. The management remains confident about growth and profit margin improvement over the next few quarters (Page 14).

From Punjab Chemicals & Crop Protection Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • The company expects a revenue growth of about 15% to 20% year-on-year over the next few years.
  • Capacity expansions and debottlenecking efforts at production sites (such as Lalru and Derabassi) aim to support higher sales volumes, targeting healthy utilizations around 80% within 4 to 6 quarters.
  • New products commercialization and MOUs are projected to generate incremental revenue of approximately INR 300-400 crores over the next 2-3 years.
  • Current capacity expansion along with new product additions could enable revenue of around INR 1,400 to INR 1,500 crores by FY 2027.

2 more points from Punjab Chemicals & Crop Protection Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Punjab Chemicals & Crop Protection Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • FY 2026 capex till 9 months: ~INR 30 crores; expected additional INR 10 crores by March 2026; total ~INR 40 crores.
  • Of FY 2026 capex, ~INR 22 crores for asset renewal/compliance; ~INR 18 crores for capacity expansion/new product flexibility.
  • FY 2027 capex expected to be ~INR 70 crores, primarily starting from March 2026, focused on new production block.
  • New manufacturing block under development to support growing demand and product additions.
  • Ongoing asset renewal programs and revamp of two production blocks to improve safety, efficiency, and reliability.

2 more points from Punjab Chemicals & Crop Protection Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
Rev 3Mar 3
3
Rev 3Mar 3
4
Rev 3Mar 3
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Punjab Chemicals & Crop Protection Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript from the Punjab Chemicals and Crop Protection Limited Q3 FY '26 earnings call does not explicitly mention the current or expected order book or pending orders. However, related insights include: - The company has signed three MOUs expected to generate incremental revenue of around INR 150-180 crores cumulatively over the next 2-3 years. - There are ongoing commercializations and trial productions of 4-7 new products this year, contributing to future revenue growth. - Supply chain shifts are influencing export versus domestic sales mix, with stable or growing export market share.

2 more points from Punjab Chemicals & Crop Protection Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Punjab Chemicals & Crop Protection Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹209 Cr, net profit ₹11 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Fertilizers & Agrochemicals this season

  • Bhagiradha Chemicals & Industries Ltd (Q3 FY26)

    114.0 crore, up 11% YoY from Rs. Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q3 FY26 investor presentation — and how it ran

  • Advance Agrolife Ltd (Q3 FY26)

    Q3 FY26 revenue from operations was ₹1,338 million, up 18% year-on-year (YoY) from ₹1,134 million in Q3 FY25 (Pages 23-24). Key investor presentation takeaways

  • Sumitomo Chemical India Ltd (Q3 FY26)

    568.0 crore, down 12% year-on-year from Rs. Key concall takeaways from Sumitomo Chemical India Ltd's Q3 FY26 earnings call — and how it ranks against sector…

  • Indogulf Cropsciences Ltd (Q3 FY26)

    The value of these export orders in hand is approximately INR 4 to 5 crores. Key concall takeaways from Indogulf Cropsci's Q3 FY26 earnings call — and how it…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Punjab Chemicals & Crop Protection Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Punjab Chemicals & Crop Protection Ltd Q3 FY26 results?

The company expects a revenue growth of about 15% to 20% year-on-year over the next few years. The management remains confident about growth and profit margin improvement over the next few quarters (Page 14).

What is Punjab Chemicals & Crop Protection Ltd share price analysis?

Punjab Chemicals & Crop Protection Ltd currently shows a neutral. The stock trades at a P/E of 20.1 with a market cap of ₹1,342 Cr. Investors should review the full earnings analysis for detailed insights.

Is Punjab Chemicals & Crop Protection Ltd planning capital expenditure?

FY 2026 capex till 9 months: ~INR 30 crores; expected additional INR 10 crores by March 2026; total ~INR 40 crores.

Keep Punjab Chemicals & Crop Protection Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.